Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Change in Cash (2020 - 2026)

BioScience Health Innovations has reported Change in Cash over the past 7 years, most recently at $483080.0 for Q1 2026.

  • Quarterly Change in Cash rose 32.05% to $483080.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $116663.0 through Mar 2026, down 87.53% year-over-year, with the annual reading at -$592.0 for FY2025, 100.09% down from the prior year.
  • Change in Cash was $483080.0 for Q1 2026 at BioScience Health Innovations, up from -$477498.0 in the prior quarter.
  • Over five years, Change in Cash peaked at $483080.0 in Q1 2026 and troughed at -$477498.0 in Q4 2025.
  • The 5-year median for Change in Cash is $20853.0 (2023), against an average of $74699.9.
  • Year-over-year, Change in Cash surged 3601.05% in 2024 and then crashed 245.01% in 2025.
  • A 5-year view of Change in Cash shows it stood at $12090.0 in 2022, then plummeted by 288.17% to -$22750.0 in 2023, then surged by 1547.46% to $329297.0 in 2024, then crashed by 245.01% to -$477498.0 in 2025, then skyrocketed by 201.17% to $483080.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Change in Cash are $483080.0 (Q1 2026), -$477498.0 (Q4 2025), and -$159984.0 (Q3 2025).